We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+2.86%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$250M
AUM Growth
+$1.55M
Cap. Flow
-$1.27M
Cap. Flow %
-0.51%
Top 10 Hldgs %
15.86%
Holding
308
New
115
Increased
19
Reduced
12
Closed
162

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$4.27M
2
WHR icon
Whirlpool
WHR
+$4.17M
3
GIS icon
General Mills
GIS
+$4.02M
4
ORCL icon
Oracle
ORCL
+$4.01M
5
MRVL icon
Marvell Technology
MRVL
+$3.99M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Industrials 15.12%
3 Healthcare 12.72%
4 Energy 12.63%
5 Consumer Discretionary 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUE icon
26
Nucor
NUE
$62.1B
$3.14M 1.25%
+63,697
New +$3.27M
RTN
27
DELISTED
Raytheon Company
RTN
$3M 1.2%
32,499
+30,299
+1,377% +$2.94M
BLK icon
28
Blackrock
BLK
$176B
$2.96M 1.18%
+9,259
New +$2.84M
SMG icon
29
ScottsMiracle-Gro
SMG
$3.66B
$2.87M 1.15%
+50,426
New +$3.01M
GPOR
30
DELISTED
Gulfport Energy Corp.
GPOR
$2.82M 1.13%
+44,949
New +$3.02M
VLO icon
31
Valero Energy
VLO
$85.9B
$2.82M 1.13%
+56,230
New +$3.1M
TSCO icon
32
Tractor Supply
TSCO
$18B
$2.8M 1.12%
+232,140
New +$3.04M
AER icon
33
AerCap
AER
$23.8B
$2.73M 1.09%
+59,633
New +$2.64M
BSX icon
34
Boston Scientific
BSX
$71.5B
$2.69M 1.07%
+210,381
New +$2.74M
CNC icon
35
Centene
CNC
$32.5B
$2.66M 1.06%
140,648
+108,536
+338% +$1.87M
CBI
36
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.65M 1.06%
+38,782
New +$3.08M
SHPG
37
DELISTED
Shire pic
SHPG
$2.52M 1.01%
10,710
+8,810
+464% +$1.53M
VOD icon
38
Vodafone
VOD
$37.4B
$2.52M 1.01%
75,358
+25,565
+51% +$905K
DGI
39
DELISTED
DigitalGlobe Inc.
DGI
$2.46M 0.98%
+88,560
New +$2.65M
ALXN
40
DELISTED
Alexion Pharmaceuticals
ALXN
$2.45M 0.98%
+15,681
New +$2.48M
ITMN
41
DELISTED
INTERMUNE INC
ITMN
$2.44M 0.98%
+55,357
New +$2.04M
CRL icon
42
Charles River Laboratories
CRL
$12.8B
$2.39M 0.95%
+44,585
New +$2.45M
XEC
43
DELISTED
CIMAREX ENERGY CO
XEC
$2.38M 0.95%
16,623
+13,987
+531% +$1.78M
CLB icon
44
Core Laboratories
CLB
$521M
$2.37M 0.95%
+14,196
New +$2.53M
SOHU
45
Sohu.com
SOHU
$357M
$2.34M 0.94%
+40,604
New +$2.37M
PZZA icon
46
Papa John's
PZZA
$806M
$2.26M 0.9%
+53,299
New +$2.37M
BCS icon
47
Barclays
BCS
$94.1B
$2.24M 0.9%
+165,760
New +$2.51M
PXD
48
DELISTED
Pioneer Natural Resource Co.
PXD
$2.07M 0.83%
8,990
-9,558
-52% -$1.97M
UAL icon
49
United Airlines
UAL
$42.1B
$2.02M 0.81%
+49,069
New +$2.11M
QCOM icon
50
Qualcomm
QCOM
$176B
$1.99M 0.8%
+25,135
New +$2M

Similar funds

Campbell & Co Investment Adviser's Q2 2014 Portfolio in Review

As of Q2 2014, Campbell & Co Investment Adviser held 308 positions worth $250M, up 0.62% from $249M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Campbell & Co Investment Adviser's Q2 2014 filing shows 115 new, 19 increased, 12 reduced and 162 closed positions. Its largest new stake was TJX Companies: 149,520 shares worth $3.97M. The largest sale was Signature Bank, an estimated $4.05M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 11% a quarter earlier, followed by Industrials and Healthcare.

  • Campbell & Co Investment Adviser's largest Q2 2014 buy was TJX Companies: 149,520 shares worth $3.97M.
  • Campbell & Co Investment Adviser added most to NVIDIA in Q2 2014, an estimated $3.77M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2014 reduction was Canadian Pacific Kansas City, cutting an estimated $2.66M.
  • Campbell & Co Investment Adviser fully exited Signature Bank in Q2 2014, selling an estimated $4.05M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 16% of its $250M portfolio in Q2 2014.
  • Campbell & Co Investment Adviser opened 115 new positions and closed 162 in Q2 2014.
  • Campbell & Co Investment Adviser's portfolio value rose 0.62% quarter-over-quarter to $250M.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2014, filed 5 Aug 2014.